The CRS Annual Meeting & Exposition brings together global experts in delivery science to share cutting-edge research, foster cross-sector collaboration, and explore innovations across academia, industry and healthcare. The event features scientific sessions, workshops, and networking opportunities designed to advance drug delivery technologies and multidisciplinary innovation.

Date: July 7-11, 2026
Location: Lisbon, Portugal
https://crs2026annualmeeting.eventscribe.net/

JOIN US!

Learn how Catalent is advancing oral drug development and delivery of macromolecules with modified release technology, bioavailability enhancement and scientific innovation. Meet with our experts to see how we can support your next breakthrough to bring better treatment to market and to patients.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Karunakar Sukuru (Karu), R.Ph., Ph.D., Global Vice President, Pharma Product Development & Head of Scientific Advisory
Date/Time: Wednesday, July 8 at 9:00am
Title: Breaking the Injection Barrier Using Innovative Technologies for Oral Delivery of Midsize and Macromolecules

Oral delivery of macromolecules such as peptides and proteins remains a major challenge due to enzymatic degradation, poor permeability and instability in the gastrointestinal tract. Despite these barriers, oral administration offers clear advantages in patient convenience, adherence and cost reduction. This presentation explores formulation and delivery strategies used to enhance oral bioavailability of macromolecules, with emphasis on lipid-based formulations, enteric softgels and sublingual/buccal routes. Mechanistic considerations including protection from gastric degradation, promotion of solubilization and modulation of intestinal absorption pathways will be discussed. By aligning molecular properties with appropriate formulation and delivery strategies, oral administration may be achievable for a specific range of peptides and biologics, supporting patient-centric product design and lifecycle differentiation.

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™